Analysis of D N manpower and management performance can provide insight into D N stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with D N A future performance. Additionally see Investing Opportunities.
D N Management EffectivenessThe company has return on total asset (ROA) of (3.05) % which means that it has lost $3.05 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (86.22) % meaning that it generated substantial loss on money invested by shareholders.
D N Workforce Comparison
D N A Biomedical Solutions Ltd is rated below average in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 1,259. D N maintains roughly 7.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
D N A Benchmark Summation
D N Stakeholders
D N employes about 7 people. The company is managed by 8 executives with total tenure of roughly 43 years, averanging almost 5.0 years of service per executive having 0.0 employee per reported executive.
|Net Loss Per Employee||9.3 M|
|Net Loss Per Executive||8.1 M|
|Working Capital Per Employee||2.6 M|
|Working Capital Per Executive||2.2 M|